Quick answer: how long does tirzepatide take to work depends on the effect. Appetite often drops within the first 1 to 3 weeks, blood sugar begins to fall within the first few weeks, and weight loss builds steadily over 3 to 18 months as the dose is raised.[3][4][6] Tirzepatide peaks in the blood about 24 hours after each injection and reaches a steady level after about 4 weeks of weekly doses.[1]
Tirzepatide is sold as Mounjaro for type 2 diabetes and Zepbound for weight management and sleep apnea. For background, see our tirzepatide profile.
Tirzepatide timeline at a glance
| When | What usually happens |
|---|---|
| Day 1-3 | Drug level peaks about 24 hours after the injection (range 8 to 72 hours)[1] |
| Week 1-3 | Less hunger and smaller meals; stomach emptying is slowest after the first dose[2][3] |
| Week 4 | Blood level reaches steady state; first dose increase allowed[1] |
| Week 4-12 | Fasting blood sugar falls in type 2 diabetes; measurable weight loss for most people[4][7] |
| Month 9-10 | Main HbA1c result in type 2 diabetes (measured at 40 weeks in SURPASS-1)[5] |
| Month 12-18 | Peak average weight loss in the main obesity trial (measured at 72 weeks)[6] |
How quickly does tirzepatide reduce appetite?
Appetite is usually the first thing people notice.
- By week 3: in a 6-week trial of 114 adults without diabetes, people on tirzepatide ate about 525 fewer calories at a test lunch than people on placebo. They also reported less overall appetite, fewer food cravings and less tendency to overeat.[3]
- Over months: in a 28-week study of people with type 2 diabetes, tirzepatide 15 mg reduced appetite and calorie intake compared with placebo.[8]
Part of the early effect comes from slower stomach emptying, which makes people feel full sooner. This effect is strongest after the first dose and fades with continued use.[2][10] Over the longer term, tirzepatide acts on GIP and GLP-1 receptors in brain areas that control appetite.[1]
How long does it take to lower blood sugar?
For people with type 2 diabetes taking Mounjaro, blood sugar starts improving quickly.
- Within 4 weeks: in an early study in type 2 diabetes, 10 mg and 15 mg lowered fasting glucose by about 49 and 43 mg/dL more than placebo over 4 weeks.[4]
- At 40 weeks: in SURPASS-1, HbA1c fell by 1.87 to 2.07 percentage points, and 87% to 92% of people reached an HbA1c below 7%.[5]
HbA1c reflects average blood sugar over roughly three months, so it lags behind daily glucose readings. The Mounjaro label says tirzepatide lowers both fasting and after-meal glucose, partly by boosting insulin release when glucose is high and by lowering glucagon.[2]
If you also take insulin or a sulfonylurea, the risk of low blood sugar rises, and your prescriber may lower those doses when tirzepatide starts.[2]
How long until you lose weight?
Weight loss takes longer than appetite changes because the dose rises step by step. Everyone starts at 2.5 mg for 4 weeks, and the dose goes up by 2.5 mg no sooner than every 4 weeks.[1] See the full tirzepatide dosage chart.
- First 3 months: in an analysis of 1,545 consistent SURMOUNT-1 users, 82% had lost at least 5% of their body weight by week 12.[7]
- Slower starters: of those who had not reached 5% by week 12, 70% got there by week 24 and 90% by week 72.[7]
- At 72 weeks: average loss was 15.0% on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg, versus 3.1% on placebo.[6]
For results by trial and dose, see tirzepatide weight loss results.
How long does tirzepatide take to work for sleep apnea?
Zepbound is approved for moderate to severe obstructive sleep apnea in adults with obesity. In the SURMOUNT-OSA trials, the main result was measured at 52 weeks, when breathing interruptions (the apnea-hypopnea index) had fallen by 25.3 and 29.3 events per hour, versus about 5 with placebo.[9] The maintenance dose for sleep apnea is 10 or 15 mg.[1] More detail is in our Zepbound sleep apnea guide.
What to track in the first months
Keeping simple notes helps you and your prescriber judge whether tirzepatide is working and whether a dose increase makes sense.
- Weight: weigh yourself at the same time of day, once a week, rather than daily. Day-to-day changes in water and food can hide the trend.
- Appetite and portions: note whether you are eating smaller meals or snacking less. This is often the first sign the drug is acting.[3]
- Blood sugar: if you have type 2 diabetes, keep a log of fasting readings. They often improve before HbA1c does.[4]
- Side effects: write down nausea, vomiting, diarrhea or constipation and when they happen relative to your injection day. Gut side effects are most common while the dose is rising.[6]
- Doses: record each injection date and dose so missed or late doses are easy to spot.
At each step on the tirzepatide dosage chart, these notes help decide whether to move up, stay put or slow down.
Why it may seem to take longer for you
- You are still on a low dose. The 2.5 mg dose is for starting treatment and is not approved as a maintenance dose.[1]
- Missed or late doses. A dose missed by more than 4 days should be skipped.[1] Gaps can slow progress.
- Type 2 diabetes. People with diabetes tend to lose less weight: 12.8% to 14.7% at 72 weeks in SURMOUNT-2.[11]
- Individual variation. Late responders in SURMOUNT-1 were more likely to be male and to start at a higher weight.[7]
If you have been on a stable dose for several months without the effect you expected, our guide to not losing weight on a GLP-1 covers next steps to discuss with your prescriber.
